结石病专家小组2025年尿路结石管理
该文为结石病专家小组(ESD 2025)关于尿路结石管理的共识性文件,从结石形成机制的多重打击假说、结石与肾损伤的关系、遗传性结石病、代谢评估、结石形态成分分析、复发与残留碎片防治、药物治疗(枸橼酸盐、植酸、可可碱、L-甲硫氨酸等)及内镜与激光技术进展等方面进行阐述。强调所有结石形成者须行结石分析和基础代谢评估,高危者须行24小时尿液专项代谢评估;形态成分分析推荐联合立体显微镜、扫描电镜-能谱分析及必要时傅里叶变换红外光谱。复发预防需生活方式、饮食与药物互补;内镜技术(fURS/RIRS)适应证因技术进步而扩展,激光热与肾内压可致肾损伤,需限制设置和改善灌注/吸引。
要点
- 所有结石形成者均须行结石分析和基础代谢评估,包括血液生化、尿沉渣、尿pH和尿培养。
- 高危结石形成者须行更具体的代谢评估,包括24小时尿液测定钙、磷、枸橼酸、草酸、尿酸、镁、钠和蛋白尿。
- 结石形态成分分析推荐联合立体显微镜、扫描电镜-能谱分析,必要时傅里叶变换红外光谱。
- 感染性鹿角石需完整手术取石、短程或长程抗生素、维持尿pH低于6.2及尿量至少2升/24小时。
- 激光碎石时限制激光设置于合理值或使用输尿管通道鞘改善液体循环以减少热释放;肾内压持续升高或压力尖峰可增加肾损伤风险。
适用人群与场景
- 结石形成者,包括遗传性高钙尿症、原发性高草酸尿症、胱氨酸尿症、腺嘌呤磷酸核糖转移酶(APRT)缺陷(与2,8-二羟基腺嘌呤结石相关)及黄嘌呤尿症患者。
- 完全性远端肾小管酸中毒发生于儿童期,表现为耳聋、佝偻病和预期寿命短;不完全性通常成年发病,主要表现为复发性尿路结石,较少见肾钙质沉着。
- 挽救性fURS适用于标准结石管理技术(如经皮肾镜取石术PCNL)禁忌或失败者,包括凝血病、病态肥胖、肾脏解剖异常(如马蹄肾或盆腔肾)、尿流改道、肾盏憩室及尿路改变的患者。
诊断标准与关键阈值
- 所有结石形成者须行结石分析和基础代谢评估,包括血液生化、尿沉渣检查、尿pH和尿培养。
- 高危结石形成者须行更具体的代谢评估,包括24小时尿液样本测定钙、磷酸盐、枸橼酸、草酸盐、尿酸、镁、钠和蛋白尿。
处置流程与药物剂量
- 鹿角石治疗须完整手术取石、短程或长程抗生素治疗、维持尿液酸化至pH低于6.2、尿量至少2升/24小时。
- L-甲硫氨酸已被证明可有效降低尿pH和鹿角石相对过饱和度。
- 碱性枸橼酸盐尤其枸橼酸钾广泛用于改变尿液化学和抑制结石形成;枸橼酸治疗的副作用为轻度胃肠道紊乱。
- 植酸对钙盐成核、生长和聚集有强抑制作用;可可碱可有效抑制尿酸结晶;枸橼酸钾与可可碱联合给药被提出作为优化尿酸溶解度和降低过度碱化及尿酸钠沉淀风险的治疗策略。
- 噻嗪类利尿剂倾向于引起低钾血症相关症状和较少见的代谢及皮肤副作用;鹿角石用尿素酶抑制剂和增强胱氨酸溶解度的药物更常与副作用相关。
- 激光热释放影响因素包括激光类型和设置、暴露时间、结石位置、光纤-结石距离、灌注量和液体循环;可通过限制激光设置于合理值或使用输尿管通道鞘(尤其可导航且带吸引者)改善液体循环来减少热释放。
- 直接镜内吸引(DISS)系统用于控制肾内压和促进残留碎片清除;柔性可导航吸引输尿管通道鞘(FANS-UAS)结合机械柔性与持续灌注管理及结石清除机制。
- 超细镜(7.5 F)便于无需预置双J管行RIRS,或使用9 F鞘为结石碎片排出或灌注获得更多空间。
红旗征与不能漏的情况
- 激光碎石时肾实质暴露于高温和高压,可能促进肾损伤;肾内压持续升高甚至压力尖峰可增加肾损伤风险。
研究设计与关键结果
- 队列研究和病例对照研究均充分证明尿路结石与肾损伤强相关;相关慢性肾损伤的主要因素包括肾实质内晶体沉积、相关合并症、反复梗阻和感染发作以及取石程序的潜在不良反应。
- 挽救性fURS在复杂或高危病例中显示良好结局,>2 cm结石的无石率为55.6%至64%。
- SWL后Clavien I-II级并发症(疼痛、血尿)发生率估计为18.43%,Clavien III-IV级并发症(血肿、脓毒症)为2.48%。
- RIRS后最常见并发症为发热或尿路感染,发生率为0.2-15%(其中尿脓毒症0.1-4.3%)。
- PCNL并发症更常见,包括需输血出血2-7%、尿脓毒症1-2%、肠损伤<1%,以及动静脉瘘0.5-1%、胸部并发症<1%。
证据类型、等级与局限
- 证据类型:结石病专家小组(ESD 2025)共识文件。
- 局限:原文未报告局限性。
对床旁实践的改变
- 所有结石形成者须行结石分析和基础代谢评估,高危者须行24小时尿液专项代谢评估。
- 结石形态成分分析推荐联合立体显微镜、扫描电镜-能谱分析及必要时傅里叶变换红外光谱,以揭示成核部位、晶体生长模式和特定成石过程。
- 鹿角石须完整手术取石、抗生素治疗、维持尿pH低于6.2及尿量至少2升/24小时。
- 激光碎石时须限制激光设置于合理值或改善液体循环以减少热释放,并通过导丝、镜体、通道鞘上的传感器实时监测肾内压。
- 智能手机应用可支持患者促进充分水化、遵循饮食建议和预防性用药依从性。
指南或共识出处
- Management of urinary stones by experts in stone disease (ESD 2025),Arch Ital Urol Androl。
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The formation of kidney stones is a complex biologic process involving interactions among genetic, anatomic, dietary, and environmental factors. Traditional lithogenic models were based on urine supersaturation in relation to the activity of crystallization promoters and inhibitors. However, modern research has added new principles such as the "renal epithelial cell response" and the role of inflammation and oxidative stress leading to the development of a "multi-hit hypothesis". A strong correlation between urinary stones and kidney damage has been well demonstrated by both cohort and case-control studies. The main contributors to chronic kidney damage associated with urinary stones include crystal deposition within the renal parenchyma, associated comorbidities, repeated obstructive and infectious episodes, as well as the potential adverse effects of stone removal procedures. Most hereditary stones may cause high urinary saturation levels promoting obstruction of the Bellini ducts and consequent glomerulosclerosis and interstitial fibrosis in the cortex. These include hereditary hypercalciurias, primary hyperoxalurias, cystinuria, adenine phosphoribosyltransferase (APRT) deficiency (associated with 2,8-dihydroxyadenine lithiasis) and xanthinuria. Complete distal renal tubular acidosis occurs in childhood and presents deafness, rickets, and a short life expectancy. The incomplete form usually manifests in adulthood, primarily with recurrent urinary lithiasis, and less frequently with nephrocalcinosis. In all stone formers stone analysis and a basic metabolic evaluation, including blood biochemistry, urine sediment examination, urinary pH and culture are mandatory, in contrast high-risk stone formers require a more specific metabolic evaluation, including a 24-hour urine sample to measure calcium, phosphate, citrate, oxalate, uric acid, magnesium, sodium and proteinuria. The morpho compositional analysis of kidney stones offers essential insights beyond merely identifying their predominant chemical component. This approach reveals key aspets of the stone formation, such as nucleation sites, crystal growth patterns, and the presence of specific lithogenic processes. The ideal analytical protocol combines stereoscopic microscopy (StM), scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM-EDS), and, when necessary, Fourier-transform infrared spectroscopy (FTIR). Recurrence prevention and managing residual fragments require complementary strategies such as lifestyle modifications, dietary interventions, and pharmacological therapies. Among pharmacological options, alkaline citrate salts, particularly potassium citrate, are widely used due to their ability to modify urinary chemistry and inhibit stone formation. Recently, novel molecules have been introduced into the management of renal stone disease. Phytate a naturally occurring polyphosphorylated carbohydrate, exibits a potent inhibitory effect on calcium salt's nucleation, growth, and aggregation. Theobromine, another natural compound, has been shown to effectively inhibit uric acid crystallization. The co-administration of urinary alkalinizing agents, such as potassium citrate, alongside theobromine has been proposed as a therapeutic strategy to optimize uric acid solubility and to reduce the risk of excessive alkalinization and subsequent sodium urate precipitation. Struvite stones are caused by urinary tract infection with urease- producing microorganisms. Their treatment requires specific measures including complete surgical stone removal, short or long-term antibiotic treatment, to maintain urinary acidification to a pH below 6.2, and a urine volume of at least 2 litres/24 hours. L-methionine has been shown to effectively lower urine pH and the relative supersaturation of struvite. An essential aspect of medical management of urinary stone disease is treatment adherence, which depends on perceived benefit, treatment duration, and side effect profile. The side effects of citrate treatment are mild gastrointestinal disorders whereas thiazide diuretics tend to cause hypokalemia-related symptoms and less frequent metabolic and dermatologic side effects. Urease inhibitors for struvite stones and drugs used to enhance cystine solubility are more frequently associated with side effects. The use of smartphone applications can support patients by promoting adequate hydration, adherence to dietary recommendations, and compliance with prophylactic medication. Endoscopic techniques currently play a prevalent role in the removal of renal stones, while extracorporeal shock wave lithotripsy is today marginally used for specific indications. Different technical modalities can be used for percutaneous nephrolithotomy (PCNL), each with its own advantages and disadvntages (standard vs. mini, prone vs. supine, fluoroscopic vs ultrasound-guided). Flexible ureteroscopy or retrograde intrarenal renal surgery (RIRS) has extended its indications due to technological advancements in endoscopes and their accessories. The availability of new laser technologies (thulium fiber laser and pulse-modulated Ho:YAG laser) has enhanced stone fragmentation and dusting capabilities. However, their use exposes the renal parenchyma to high temperatures and pressures which could potentially contribute to renal damage. Factors influencing heat release include laser type and settings, exposure time, stone location, fiber-to-stone distance, irrigation volume and fluid circulation. Reduction of heat release can be achieved by limiting the laser settings to reasonable values or by improving fluid circulation with use of ureteral access sheaths, especially those navigable and equipped with suction. High intrarenal pressure is also closely associated with renal damage. Sustained high pressure or even pressure spikes may increase this risk, highlighting the importance of real-time pressure monitoring through sensors integrated on guidewires, scopes, access sheath and use of innovative platforms regulating irrigation/suction systems. Direct In-Scope Suction (DISS) system was developed to control intrarenal pressure and facilitate the removal of residual fragments. Flexible and Navigable Suction Ureteral Access Sheath (FANS-UAS) is a flexi-bendable UAS equipped with suction capabilities combining mechanical flexibility with continuous irrigation management and stone clearance mechanisms. Ultra-thin scopes (7.5 F) make it easy to perform RIRS without the need for pre-placed double-J stents or with a 9 F sheath achieving more space for stone fragments expulsion or infusion. All these technological advancements have enhanced the efficacy of fURS or RIRS which can be an alternative treatment (salvage fURS) when standard stone management techniques, such as percutaneous nephrolithotomy (PCNL), are contraindicated or fail. Salvage fURS has shown favorable outcomes in complex or high-risk cases, including patients with coagulopathies, morbid obesity, renal anatomical abnormalities (e.g., horseshoe or pelvic kidneys), urinary diversion, calyceal diverticula, and altered urinary tracts. In such scenarios it demonstrated favorable outcomes with stone-free rates ranging from 55.6% to 64% for stones > 2 cm. Although non-invasive, extracorporeal and endoscopic treatments for renal and ureteral stones carry a risk of complications that can be classified according to the Clavien-Dindo system. The complication rate after SWL was estimated at 18.43% for Clavien grade I-II complications (pain, hematuria) and 2.48% for Clavien III-IV complications (hematoma, sepsis). The most frequent complication after RIRS is fever or urinary tract infection observed in 0.2-15% (with 0.1-4.3% of cases of urinary sepsis). Complications after PCNL are more frequent and may include moderate events (hemorrhage requiring transfusion 2-7%, urosepsis 1-2%, bowel injury < 1%) as well as severe events (arteriovenous fistula 0.5-1%, thoracic complications < 1% , loss of access tract 1-3%, death < 0.5%). The risk of bleeding complications is significantly increased in patients on antithrombotic therapy. A personalized, interdisciplinary approach enables optimal decision-making in balancing antithrombotic therapy with surgical safety during urological stone interventions Finally, it must be considered that endourological procedures can be harmful to the surgeons themselves and their team due to exposure to ionizing radiation. For this reason, procedures must be carried out in strict accordance with safety guidelines and regulations to minimize radiation exposure. Safety is vital in any surgical intervention, with efficacy being the next most critical consideration. However, cost-effectiveness should be also considered. Endourology involves high costs largely due to the use of sophisticated equipment that requires frequent renewal due to the continuous rapid technological evolution. Using disposable devices brings numerous benefits but also leads to a further increase in costs. Finally, in the cost-benefit assessment, the rate of reintervention associated with some types of procedures must be considered.
参考来源
- Papatsoris A, Geavlete B, Radavoi GD, et al. Management of urinary stones by experts in stone disease (ESD 2025). Arch Ital Urol Androl. 2025. PMID: 40583613. doi:10.4081/aiua.2025.14085
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。